Selegiline initial adjunctive therapy Parkinson disease Parkinson disease PD progressive neurologic motor disorder Currently levodopa/carbidopa standard mode therapy PD progression disease Selegiline deprenyl selective irreversible monoamine oxidase type inhibitor devoid tyramine reaction recommended dosage mg/d Food Drug Administration adjunctive use management patients PD levodopa/carbidopa wearing effect levodopa Numerous clinical trials selegiline role treatment PD Preliminary evidence DATATOP trial selegiline progression PD initial therapy final results trial additional long-term trials selegiline groups necessary selegiline role treatment PD 